Chemistry:Mibolerone

From HandWiki
Short description: Chemical compound
Mibolerone
Mibolerone structure.png
Mibolerone molecule ball.png
Clinical data
Trade namesCheque Drops, Matenon
Other namesU-10997; CDB-904; Dimethylnandrolone; Dimethylnortestosterone;[1] DMNT; 7α,17α-Dimethyl-19-nortestosterone; 7α,17α-Dimethylestr-4-en-17β-ol-3-one
AHFS/Drugs.comInternational Drug Names
Routes of
administration
By mouth
Drug classAndrogen; Anabolic steroid; Progestogen
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
MetabolismLiver
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC20H30O2
Molar mass302.458 g·mol−1
3D model (JSmol)
  (verify)

Mibolerone, also known as dimethylnortestosterone (DMNT) and sold under the brand names Cheque Drops and Matenon, is a synthetic, orally active, and extremely potent anabolic–androgenic steroid (AAS) and a 17α-alkylated nandrolone (19-nortestosterone) derivative which was marketed by Upjohn for use as a veterinary drug.[2][3][4] It was indicated specifically as an oral treatment for prevention of estrus (heat) in adult female dogs.[2]

Side effects

Pharmacology

Pharmacodynamics

Mibolerone has both higher affinity and greater selectivity for the androgen receptor (AR) than does the related potent AAS metribolone (17α-methyl-19-nor-δ9,11-testosterone),[5][6] although potent and significant progestogenic activity remains present.[7] However, another study found that mibolerone and metribolone had similar affinity for the progesterone receptor (PR) but that mibolerone only had around half the affinity of metribolone for the AR.[8]

Relative affinities (%) of mibolerone and related steroids[9][10]
Compound Chemical name PR AR ER GR MR
Testosterone T 1.0 100 <0.1 0.17 0.9
Nandrolone 19-NT 20 154 <0.1 0.5 1.6
Trenbolone 9,11-19-NT 74 197 <0.1 2.9 1.33
Trestolone 7α-Me-19-NT 50–75 100–125 ? <1 ?
Normethandrone 17α-Me-19-NT 100 146 <0.1 1.5 0.6
Metribolone 9,11-17α-Me-19-NT 208 204 <0.1 26 18
Mibolerone 7α,17α-DiMe-19-NT 214 108 <0.1 1.4 2.1
Dimethyltrienolone 9,11-7α,17α-DiMe-19-NT 306 180 0.1 22 52
Values are percentages (%). Reference ligands (100%) were progesterone for the PR, testosterone for the AR, estradiol for the ER, DEXA for the GR, and aldosterone for the MR.

Chemistry

Mibolerone, also known as 7α,17α-dimethyl-19-nortestosterone (DMNT) or as 7α,17α-dimethylestr-4-en-17β-ol-3-one,[7] is a synthetic estrane steroid and a 17α-alkylated derivative of nandrolone (19-nortestosterone). It is the 17α-methyl derivative of trestolone (7α-methyl-19-nortestosterone; MENT).[7] Other related AAS include metribolone (17α-methyl-δ9,11-19-nortestosterone) and dimethyltrienolone (7α,17α-dimethyl-δ9,11-19-nortestosterone).

Synthesis

Nandrolone (1) appears to be used to make mibolerone. For comparison, also see bolasterone and calusterone. The first step involves extending the conjugation of the enone function by an additional double bond. Chloranil (tetrachloroquinone) is the forerunner of dichlorodicyanoquinone (DDQ), a reagent used extensively for introducing additional unsaturation in the progestin and corticoid series.

Preparation of Mibolerone: BE patent 610385; J. C. Babcock, J. A. Campbell, U.S. Patent 3,341,557 (1962, 1967 both to Upjohn).

In the case at hand, heating acetate (1) with chloranil gives the conjugated dienone (2), and reaction of that compound with methylmagnesium bromide in the presence of cuprous chloride leads to addition of the methyl group to position 7 at the end of the conjugated system (3). The stereochemistry of the product again illustrates the preference for additions from the backside. The alcohol at C17 is then oxidized to a ketone (4). Enamines are commonly used to activate adjacent functions; they are also not infrequently used, as in this case, as protecting groups. Thus, reaction of the intermediate with pyrrolidine gives dienamine (5). This transformation emphasizes the clear difference in reactivity between ketones at C7 and C17. A second methyl Grignard addition gives the corresponding 17α-methyl derivative. Hydrolysis of the enamine function then affords mibolerone (6).

The same structure of 3 and 4 also containing an 11β-fluoro group has also been described in the patent literature.[11]

History

Mibolerone was first synthesized in 1963.[12][4]

Society and culture

Generic names

Mibolerone is the generic name of the drug and its INN, USAN, and BAN.[2][3] It is also known as dimethylnortestosterone (DMNT) and by its former developmental code name U-10997.[2][3]

Brand names

Mibolerone has been marketed under the brand names Cheque Drops and Matenon.[3][2][4]

References

  1. Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. 31 October 1999. pp. 181–. ISBN 978-0-7514-0499-9. https://books.google.com/books?id=mqaOMOtk61IC&pg=PA181. 
  2. 2.0 2.1 2.2 2.3 2.4 The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014. pp. 822–. ISBN 978-1-4757-2085-3. https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA822. 
  3. 3.0 3.1 3.2 3.3 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 689–. ISBN 978-3-88763-075-1. https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA689. 
  4. 4.0 4.1 4.2 William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 395–. ISBN 978-0-9828280-1-4. https://books.google.com/books?id=afKLA-6wW0oC&pg=PT395. 
  5. "Characterization of steroid receptors in human prostate using mibolerone". Prostate 8 (3): 241–53. 1986. doi:10.1002/pros.2990080305. PMID 2422638. 
  6. "The use of radioactive 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) in the assay of androgen receptors". Prostate 5 (6): 581–8. 1984. doi:10.1002/pros.2990050603. PMID 6333679. 
  7. 7.0 7.1 7.2 "Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays". Methods Find Exp Clin Pharmacol 19 (4): 215–22. 1997. PMID 9228646. 
  8. "A comparison of progestin and androgen receptor binding using the CoMFA technique". J. Comput.-Aided Mol. Des. 6 (6): 569–81. 1992. doi:10.1007/bf00126215. PMID 1291626. Bibcode1992JCAMD...6..569L. 
  9. "Steroid flexibility and receptor specificity". J. Steroid Biochem. 13 (1): 45–59. January 1980. doi:10.1016/0022-4731(80)90112-0. PMID 7382482. 
  10. "Towards the mapping of the progesterone and androgen receptors". J. Steroid Biochem. 27 (1–3): 255–69. 1987. doi:10.1016/0022-4731(87)90317-7. PMID 3695484. 
  11. U.S. Patent 7,361,645 (2008 to Bayer Schering Pharma Ag).
  12. "Metabolism of anabolic androgenic steroids". Clin. Chem. 42 (7): 1001–20. 1996. doi:10.1093/clinchem/42.7.1001. PMID 8674183. 

External links


{{Navbox

| name = Androgens and antiandrogens
| title = Androgens and antiandrogens
| state = collapsed
| listclass = hlist
| groupstyle = text-align:center;
| group1 = Androgens
(incl. AAS)

| list1 =

  | group3 = Antigonadotropins
  | list3 =
  | group4 = Others
  | list4 =
}}
| liststyle = background:#DDDDFF;
| list3 =
See also
Androgen receptor modulators
Estrogens and antiestrogens
Progestogens and antiprogestogens
List of androgens/anabolic steroids

}}